Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| tofimilast | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in FEV1 compared to placebo |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in other lung function parameters, dyspnea, quality of life compared to placebo |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | 85006 | United States | ||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Riverside |
| California |
| 92506 |
| United States |
| Pfizer Investigational Site | Clearwater | Florida | 33756 | United States |
| Pfizer Investigational Site | Clearwater | Florida | 33765 | United States |
| Pfizer Investigational Site | Riverdale | Georgia | 30296 | United States |
| Pfizer Investigational Site | Stockbridge | Georgia | 30281 | United States |
| Pfizer Investigational Site | Normal | Illinois | 61761 | United States |
| Pfizer Investigational Site | Iowa City | Iowa | 52240 | United States |
| Pfizer Investigational Site | Madisonville | Kentucky | 42431 | United States |
| Pfizer Investigational Site | Wheaton | Maryland | 20902 | United States |
| Pfizer Investigational Site | Edina | Minnesota | 55438 | United States |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55407 | United States |
| Pfizer Investigational Site | Buffalo | New York | 14215-1199 | United States |
| Pfizer Investigational Site | Charlotte | North Carolina | 28207 | United States |
| Pfizer Investigational Site | Cincinnati | Ohio | 45241 | United States |
| Pfizer Investigational Site | Lake Oswego | Oregon | 97035 | United States |
| Pfizer Investigational Site | Lincoln | Rhode Island | 02865 | United States |
| Pfizer Investigational Site | Spartanburg | South Carolina | 29303 | United States |
| Pfizer Investigational Site | Spartanburg | South Carolina | 29307 | United States |
| Pfizer Investigational Site | Dallas | Texas | 75231 | United States |
| Pfizer Investigational Site | Bellingham | Washington | 98226 | United States |
| Pfizer Investigational Site | Renton | Washington | 98055 | United States |
| Pfizer Investigational Site | Tukwila | Washington | 98188 | United States |
| Pfizer Investigational Site | La Plata | Buenos Aires | C1904AGP | Argentina |
| Pfizer Investigational Site | Vicente López | Buenos Aires | 1602 | Argentina |
| Pfizer Investigational Site | Rosario | Santa Fe Province | 2000 | Argentina |
| Pfizer Investigational Site | Buenos Aires | 1426 | Argentina |
| Pfizer Investigational Site | Buenos Aires | C1425BEA | Argentina |
| Pfizer Investigational Site | Buenos Aires | C1425DQU | Argentina |
| Pfizer Investigational Site | Curitiba | Paraná | 80060-900 | Brazil |
| Pfizer Investigational Site | Porto Alegre | Rio Grande do Sul | 90035-002 | Brazil |
| Pfizer Investigational Site | Porto Alegre | Rio Grande do Sul | 90610-000 | Brazil |
| Pfizer Investigational Site | Providencia | Santiago Metropolitan | Chile |
| Pfizer Investigational Site | Recoleta | Santiago Metropolitan | Chile |
| Pfizer Investigational Site | Santiago | Chile |
| Pfizer Investigational Site | ValparaÃ-so | Chile |
| Pfizer Investigational Site | San José | Provincia de San José | Costa Rica |
| Pfizer Investigational Site | México | D.f. | 14080 | Mexico |
| Pfizer Investigational Site | Monterrey | Nuevo León | Mexico |
| Pfizer Investigational Site | Monterrey | Nuevo León | 64460 | Mexico |
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| C517806 | tofimilast |
Not provided
Not provided
Not provided